Abbott Launches Leadless Pacemaker in India
By Rediff Money Desk, New Delhi Nov 22, 2024 13:33
Abbott introduces AVEIR VR leadless pacemaker in India for patients with slow heart rhythms. The device is FDA-approved and aims to simplify implantation and retrieval processes.
New Delhi, Nov 22 (PTI) Drug firm Abbott has launched a pacemaker in India for the treatment of patients with slow heart rhythms.
Abbott has introduced AVEIR VR single-chamber ventricular leadless pacemaker which has been approved by the Central Drugs Standard Control Organisation, the company said in a statement on Friday.
The product has also been approved by the US Food and Drug Administration (USFDA).
"The AVEIR VR leadless pacemaker was designed to make the implantation and retrieval processes as seamless as possible for physicians and provide improvements over existing options," said Ajay Singh Chauhan, General Manager for Abbott's Cardiac Rhythm Management business in India, Southeast Asia, HK, Taiwan & Korea.
People who experience slower-than-normal heart rhythm may receive a pacemaker to deliver pulses of electricity to trigger the heart to beat properly.
Balbir Singh, Chairman Cardiology, Max Superspeciality Hospital said, "Leadless pacemakers address known complications associated with traditional pacemakers."
While traditional pacemakers require a chest incision and pocket for the generator along with one or more insulated wires 'known as cardiac leads 'to deliver electricity to the heart, leadless pacemakers do not require a pocket or leads.
"In some circumstances where we believe a person's therapy needs may change in the future, retrievability also becomes a critical device feature," Vanita Arora, Clinical Lead Electrophysiology, Apollo Hospitals Delhi said.
Abbott has introduced AVEIR VR single-chamber ventricular leadless pacemaker which has been approved by the Central Drugs Standard Control Organisation, the company said in a statement on Friday.
The product has also been approved by the US Food and Drug Administration (USFDA).
"The AVEIR VR leadless pacemaker was designed to make the implantation and retrieval processes as seamless as possible for physicians and provide improvements over existing options," said Ajay Singh Chauhan, General Manager for Abbott's Cardiac Rhythm Management business in India, Southeast Asia, HK, Taiwan & Korea.
People who experience slower-than-normal heart rhythm may receive a pacemaker to deliver pulses of electricity to trigger the heart to beat properly.
Balbir Singh, Chairman Cardiology, Max Superspeciality Hospital said, "Leadless pacemakers address known complications associated with traditional pacemakers."
While traditional pacemakers require a chest incision and pocket for the generator along with one or more insulated wires 'known as cardiac leads 'to deliver electricity to the heart, leadless pacemakers do not require a pocket or leads.
"In some circumstances where we believe a person's therapy needs may change in the future, retrievability also becomes a critical device feature," Vanita Arora, Clinical Lead Electrophysiology, Apollo Hospitals Delhi said.
Source: PTI
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.
You May Like To Read
TODAY'S MOST TRADED COMPANIES
- Company Name
- Price
- Volume
- Srestha Finvest
- 0.57 ( -9.52)
- 60265410
- Vodafone Idea L
- 8.27 (+ 0.73)
- 44071594
- YES Bank Ltd.
- 17.67 ( -0.56)
- 16081247
- G G Engineering
- 1.06 ( -4.50)
- 15019273
- Remedium Lifecare
- 3.97 (+ 4.75)
- 11827509
MORE NEWS

India's FM: Govt & RBI Working Together to...
India's Finance Minister Nirmala Sitharaman says the government and Reserve Bank are...
Dhankhar: Research Key to Economic Supremacy
Vice President Jagdeep Dhankhar stresses research as the foundation of economic power...

Sebi Bans Two Portfolio Managers for Net Worth...
Sebi barred Scient Capital and DGS Capital Management from onboarding new clients after...